Literature DB >> 8001005

Endocrine gland cancer.

P Correa1, V W Chen.   

Abstract

BACKGROUND: Incidence and prognosis of cancers of the endocrine glands vary greatly by histologic type.
METHODS: Population-based data from SEER registries, 1973-1987, were analyzed.
RESULTS: Thyroid cancer accounts for most (92%) of the cancers of the endocrine glands. The four major histologic types of thyroid cancer display distinct patterns, reflecting different biologic entities. Papillary carcinoma, the most common type, occurs more frequently in women than in men and in whites than in blacks and has an early onset. Follicular carcinoma, the second most common type, shows a steady increase in incidence with age and a female preponderance but no racial disparity. Medullary carcinoma, the rare differentiated thyroid tumor, has a female excess in whites only and a slow increase in incidence with age. Anaplastic carcinoma shows few racial or sex variations and reaches a substantial level only after age 50. The prognosis also varies greatly by histologic type. The overall 5-year relative survival rate is greater than 90% for papillary and follicular carcinomas, 82% for medullary carcinoma, and less than 10% for anaplastic carcinoma. Carcinomas of the suprarenal gland and thymus are rare, accounting for about 3% of endocrine cancers each. These tumors, unlike the differentiated thyroid cancer, show no female preponderance, have a higher incidence rate in blacks, and have a poorer survival rate.
CONCLUSIONS: The marked predominance of papillary carcinoma and the continued increase in its relative frequency characterize the postgoiter era and an increased use of scintigraphy and fine needle aspiration. Underdiagnosis of small tumors may explain the observed lower incidence of papillary carcinoma in blacks.

Entities:  

Mesh:

Year:  1995        PMID: 8001005     DOI: 10.1002/1097-0142(19950101)75:1+<338::aid-cncr2820751316>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  21 in total

Review 1.  A diagnostic approach to adrenal cortical lesions.

Authors:  Anne Marie McNicol
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

2.  Follicular adenoma and carcinoma of the thyroid gland.

Authors:  Christopher R McHenry; Roy Phitayakorn
Journal:  Oncologist       Date:  2011-04-11

Review 3.  Use of fertility medications and cancer risk: a review and update.

Authors:  Lindsay Kroener; Daniel Dumesic; Zain Al-Safi
Journal:  Curr Opin Obstet Gynecol       Date:  2017-08       Impact factor: 1.927

4.  Immunohistochemical Expression of Estrogen Receptor-α and Progesterone Receptor in Patients with Papillary Thyroid Cancer.

Authors:  Giacomo Sturniolo; Carles Zafon; Mariacarla Moleti; Josep Castellví; Francesco Vermiglio; Jordi Mesa
Journal:  Eur Thyroid J       Date:  2016-11-24

5.  Thyroidectomy and lymph node dissection in papillary thyroid carcinoma.

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  J Thyroid Res       Date:  2010-11-10

6.  Thyroid cancer and thyroiditis in Salta, Argentina: a 40-yr study in relation to iodine prophylaxis.

Authors:  H Rubén Harach; Dardo A Escalante; Ernesto Saravia Day
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

7.  Thyroid Carcinoma in Japan and the West: Similarities and Differences.

Authors:  Shinobu Nakamura; Hiroyuki Nakamura; Yuji Mizukami
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

8.  Undifferentiated (anaplastic) thyroid carcinoma and iodine intake in Salta, Argentina.

Authors:  H R Harach; Macarena Galíndez; Mónica Campero; G A Ceballos
Journal:  Endocr Pathol       Date:  2013-09       Impact factor: 3.943

9.  Follicular Thyroid Carcinoma: Disease Response Evaluation Using American Thyroid Association Risk Assessment Guidelines.

Authors:  Aamna Hassan; Madeeha Khalid; Saima Riaz; M Khalid Nawaz; Humayun Bashir
Journal:  Eur Thyroid J       Date:  2015-11-25

10.  Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway.

Authors:  Q Zeng; G G Chen; A C Vlantis; C A van Hasselt
Journal:  Cell Prolif       Date:  2007-12       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.